Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for Newly Diagnosed Essential Hypertension in Adolescents
NCT00288184Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Sep 2004
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of allopurinol in essential hypertension, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Sep 2004; status: completed.
02
Drugs
allopurinol
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00288184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288184.